This content is machine translated Diabetes Management Fresh wind through new possibilities – what is now possible In addition to the metabolic syndrome, type 2 diabetes also affects the blood vessels, heart and kidneys, among other things – this has been revealed by scientific research into the…
View Post 2 min This content is machine translated Glucagon-like peptide 1 (GLP1) analogues The future of diabetes management has begun Diabetes does not hurt – one would almost like to add “unfortunately”. This is because the number of unreported cases of affected patients is still high. Possible late effects of…
View Post 4 min This content is machine translated Psoriasis infestation of scalp, nails and palmoplantar Excellent long-term data – IL23 inhibitor improves symptoms and quality of life Psoriasis in highly visible locations is particularly stigmatizing for patients. There is a high demand for effective and safe treatment options, especially for severe forms of the disease. Of those…
View Post 2 min This content is machine translated Advanced training with case studies Type 2 diabetes and heart Type 2 diabetes mellitus and cardiovascular disease are closely linked. Thus, diabetes is not only one of the most important cardiovascular risk factors, but also increases the morbidity and mortality… CME-Test
View Post 6 min This content is machine translated Diabetes mellitus Biomarker-associated clustering for improved treatment management. Phenotyping and subclassification of diabetic patients is becoming increasingly important to provide patient-adapted treatment options. Meanwhile, there are several cluster analyses that could reveal certain specific patterns of patient characteristics.…
View Post 4 min This content is machine translated Type 2 diabetes: Update 2021 SGLT-2 inhibitors and GLP-1-RA: added value to treatment. Early detection and follow-up are critical for the management of type 2 diabetes mellitus. This is more relevant than ever in the current COVID 19 pandemic. The goals of modern diabetes…
View Post 7 min This content is machine translated Rheumatoid arthritis Lasting remission through targeted treatment Despite great advances in the management of rheumatoid arthritis, many patients do not respond satisfactorily (or adequately) to available treatments [1]. Data from clinical trials of a targeted disease-modifying antirheumatic…
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 1: SGED Recommendations The digital and CME-certified continuing education series “Dia-Month Club” on type 2 diabetes started on April 30.Our expert, Prof. Roger Lehmann (University Hospital Zurich), explains in the first module the… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 2: (Post-)Pandemic On May 17, the second module of the Dia-Month Club on the (post)pandemic took place. Our expert, Prof. Marc Donath (University Hospital Basel), spoke on the exciting question: Does Covid-19… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 3: LDL cholesterol On June 25, the third module of the Dia-Month Club took place, focusing on an often underestimated risk factor, LDL cholesterol. Our expert, Prof. Isabella Sudano (University Hospital Zurich), presented… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 4: Heart In the fourth module of the Dia-Month Club on September 3, Prof. Christian Müller (University Hospital Basel) used current data to show how modern diabetes management decisively reduces the patient’s… CME-Test
